D. Western Therapeutics Institute
4576
Needs Well
3992
Daiwa Cycle
5888
Osaka Yuka Industry
4124
Liberta
4935
(FY)Jan 31, 2024 | (FY)Jan 31, 2023 | (FY)Jan 31, 2022 | (FY)Jan 31, 2021 | (FY)Jan 31, 2020 | (FY)Jan 31, 2019 | (FY)Jan 31, 2018 | (FY)Jan 31, 2017 | (FY)Jan 31, 2016 | |
---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||||||
Cash from operating activities | 42.55%558.02M | 30.97%391.47M | 17.68%298.9M | 25.22%254M | 24.47%202.84M | 1.47%162.97M | 67.80%160.61M | 735.54%95.72M | -15.06M |
Net profit before non-cash adjustment | 37.91%482.86M | 29.30%350.14M | 51.86%270.79M | 20.96%178.31M | 8.51%147.42M | 13.92%135.86M | 134.39%119.26M | 360.47%50.88M | ---19.53M |
Total adjustment of non-cash items | 18.98%2.83M | 24.91%2.38M | 13.51%1.91M | 32.70%1.68M | -30.40%1.27M | -14.76%1.82M | -13.46%2.13M | 44.38%2.47M | --1.71M |
-Depreciation and amortization | 18.86%2.85M | 24.84%2.4M | 12.81%1.92M | 46.60%1.7M | -16.95%1.16M | -19.38%1.4M | -18.17%1.73M | 28.97%2.12M | --1.64M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---83K |
-Other non-cash items | 0.00%-15K | -15.38%-15K | 40.91%-13K | -120.95%-22K | -75.06%105K | 5.25%421K | 15.27%400K | 134.46%347K | --148K |
Changes in working capital | 85.70%72.32M | 48.61%38.95M | -64.59%26.21M | 36.65%74M | 114.15%54.16M | -35.52%25.29M | -7.44%39.22M | 1,432.41%42.37M | --2.77M |
-Change in receivables | 16.37%-42.4M | -45.61%-50.7M | -204.61%-34.82M | -0.09%-11.43M | 19.10%-11.42M | -1,629.36%-14.12M | 131.54%923K | 87.24%-2.93M | ---22.93M |
-Change in prepaid assets | 14.30%55.43M | 55.12%48.5M | 38.62%31.27M | -9.86%22.56M | 6.99%25.02M | -39.23%23.39M | --38.49M | ---- | ---- |
-Change in payables | 5.53%48.32M | 75.54%45.79M | 44.98%26.09M | 10.60%17.99M | 61.27%16.27M | 450.73%10.09M | -124.89%-2.88M | -26.93%11.56M | --15.82M |
-Provision for loans, leases and other losses | 34.73%1.94M | -33.38%1.44M | 19.11%2.16M | -8.12%1.81M | -30.23%1.97M | 115.32%2.83M | 236.95%1.31M | ---958K | ---- |
-Changes in other current assets | 54.86%-4.06M | -915.32%-8.99M | -97.12%1.1M | 252.19%38.34M | 392.80%10.89M | 142.52%2.21M | -115.65%-5.2M | 1,502.24%33.21M | ---2.37M |
-Changes in other current liabilities | 349.54%13.09M | 603.14%2.91M | -91.26%414K | -58.56%4.74M | 1,175.78%11.43M | -86.36%896K | 339.92%6.57M | -87.81%1.49M | --12.25M |
Dividends paid (cash flow from operating activities) | |||||||||
Dividends received (cash flow from operating activities) | |||||||||
Interest paid (cash flow from operating activities) | 74.13%-112K | -6.91%-433K | -10.66%-405K | -61.95%-366K | -226K | ||||
Interest received (cash flow from operating activities) | 0.00%15K | 15.38%15K | -40.91%13K | 22.22%22K | 50.00%18K | 140.00%12K | -76.19%5K | -68.18%21K | 66K |
Tax refund paid | -24.13%-131.76M | -60.14%-106.14M | -24.86%-66.28M | 16.04%-53.08M | 5.24%-63.22M | -2,200.76%-66.72M | -2,512.61%-2.9M | 72.86%-111K | -409K |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%-1K | -1K |
Operating cash flow | 49.39%426.28M | 22.66%285.34M | 15.78%232.64M | 44.02%200.94M | 45.60%139.52M | -39.08%95.83M | 65.14%157.31M | 709.44%95.26M | ---15.63M |
Investing cash flow | |||||||||
Net PPE purchase and sale | -2,515.44%-3.9M | 63.83%-149K | 94.36%-412K | -4,026.55%-7.3M | 87.95%-177K | ---1.47M | ---- | ---- | ---4.34M |
Net intangibles purchase and sale | --0 | ---7.38M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | 0.00%-30M | -0.00%-30M | 0.03%-30M | -0.04%-30.01M | 0.00%-30M | 0.00%-30M | ---30M | ---- | ---- |
Advance cash and loans provided to other parties | --0 | ---500K | --0 | ---- | ---3M | ---- | ---- | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | --500K | ---- | -66.67%500K | 50.00%1.5M | --1M | ---- | ---- | ---- | ---- |
Net changes in other investments | ---1K | ---- | ---1K | ---- | ---- | ---- | ---- | -386.01%-30.6M | --10.7M |
Investing cash flow | 12.18%-33.4M | -27.13%-38.03M | 16.47%-29.92M | -11.31%-35.82M | -2.25%-32.18M | -4.90%-31.47M | 1.96%-30M | -581.51%-30.6M | --6.36M |
Financing cash flow | |||||||||
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---30M | ---- | ---- | ---- | ---23M |
Net common stock issuance | ---112K | --0 | 42.11%-55K | -126.19%-95K | -100.01%-42K | --517.08M | ---- | ---- | --40.16M |
Cash dividends paid | -30.27%-63.58M | -0.15%-48.81M | -99.29%-48.73M | ---24.45M | ---- | ---- | ---- | ---- | ---- |
Net other fund-raising expenses | ---1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Financing cash flow | -30.50%-63.69M | -0.04%-48.81M | -98.75%-48.79M | 18.29%-24.55M | -105.81%-30.04M | --517.08M | ---- | ---- | --17.16M |
Net cash flow | |||||||||
Beginning cash position | 16.88%1.37B | 15.06%1.18B | 15.94%1.02B | 9.61%881.68M | 260.81%804.37M | 133.14%222.93M | 208.85%95.62M | 34.18%30.96M | --23.08M |
Current changes in cash | 65.83%329.18M | 28.95%198.5M | 9.50%153.93M | 81.84%140.57M | -86.70%77.31M | 356.71%581.44M | 96.89%127.31M | 719.95%64.66M | --7.89M |
Cash adjustments other than cash changes | ---1K | ---- | ---1K | ---- | 0.00%-1K | ---1K | ---- | ---- | ---- |
End cash Position | 23.95%1.7B | 16.88%1.37B | 15.06%1.18B | 15.94%1.02B | 9.61%881.68M | 260.81%804.37M | 133.14%222.93M | 208.85%95.62M | --30.96M |
Free cash flow | 52.04%422.38M | 19.63%277.81M | 19.93%232.22M | 38.96%193.63M | 47.68%139.35M | -40.02%94.36M | 65.14%157.31M | 576.90%95.26M | ---19.98M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |